Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells

Detalles Bibliográficos
Autores principales: Valsesia-Wittmann, Sandrine, Clemenceau, Beatrice, Jallas, Anne-Catherine, Blay, Jean-Yves, Marabelle, Aurelien, Caux, Christophe, Vie, Henri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991297/
http://dx.doi.org/10.1186/2051-1426-1-S1-P176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991297/
http://dx.doi.org/10.1186/2051-1426-1-S1-P176

Ejemplares similares